foxo4-dri clinical trial human — ≥99% Purity, COA Included FOXO4-DRI - Simon's Compounding
FOXO4 DRI Simon's Compounding FOXO4 DRI FOX04 DRI 10mg Battle Born Peptides FOXO4 DRI PEPTIDE 2MG 5MG 10MG VIAL UMBRELLA Labs FOXO4 DRI (10mg) The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $7.40 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5





